Nuzhat Arshad

Dr. Nuzhat Arshad


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
NANuzhat Arshad
Nuzhat Arshad
JAMSHED HASHIMJAMSHED HASHIM
JAMSHED HASHIM
IRIrfanullah
Irfanullah
MMMuhammad Ali Minhas
Muhammad Ali Minhas
JAJaveria Aslam
Javeria Aslam
SJShumaila Javed
Shumaila Javed

1 November 2024 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
MAMasooma Abbas
Masooma Abbas
NANuzhat Arshad
Nuzhat Arshad

14 November 2022 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
NANuzhat Arshad
Nuzhat Arshad
SJShumaila Jawaid
Shumaila Jawaid
JHJamshed Hashim
Jamshed Hashim
IUIrfan Ullah
Irfan Ullah
SGSomia Gul
Somia Gul
AKAlamzeb Khan
Alamzeb Khan

1 January 2021 in HETEROCYCLES
Verified
Journal Article
Closed access
JAMSHED HASHIMJAMSHED HASHIM
JAMSHED HASHIM
NANuzhat Arshad
Nuzhat Arshad
MYMuhammad Yaseen
Muhammad Yaseen
RKRasool Khan
Rasool Khan
TITahseen Iqbal
Tahseen Iqbal
IUIrfan Ullah
Irfan Ullah

2 May 2025 in Molecules
Verified
Journal Article
Open access
PDF file
HSHira Sultan
Hira Sultan
NANuzhat Arshad
Nuzhat Arshad
MLMehreen Lateef
Mehreen Lateef
Crown ethers have gained importance in the field of medicine because of their resemblance to natural ionophores like valinomycin. With the goal of developing new pharmacologically important crown ethers, a novel series of crown ethers linked with Fusidic acid butyl ester 10a–d were synthesized and characterized by means of their 1H NMR, 13C NMR DEPT-135, FT-IR, and mass spectrometry. In vitro antioxidant and α-glucosidase inhibition activities of all crown ethers along with the precursor Fusidic acid butyl ester were examined and compared to the standard butylated hydroxyanisole and acarbose, respectively. Compounds (FABE-16-crown-4) 10b and (FABE-19-crown-5) 10c showed high antioxidant potential with the IC50 = 22.5 ± 0.2 μM and 32.1 ± 0.3 μM, respectively, when compared to the standard BHA (IC50 = 44.2 ± 0.34 μM). To understand the binding mode of the compounds, molecular docking investigations were performed using human antioxidant protein, peroxiredoxin 5. Molecular docking studies revealed higher docking scores (−6.5 and −6.7 kcal/mol) for the highly active compounds 10c and 10b, respectively, than standard BHA (−5.3 kcal/mol). Synthesized crown ethers exhibited moderate α-glucosidase inhibition with (IC50 = 23.5 ± 0.2 to 76.5 ± 0.1 μM) when compared to acarbose as standard (IC50 = 5.2 ± 0.8 μM). The in silico ADMET predictions indicated that the prepared compounds obeyed (bRO5) and Veber’s rule for the acceptance as orally administered drugs and indicated that all the prepared crown ethers exhibited calculated values of drug likeness parameters in acceptable ranges that showed good potential of these molecules for further drug development investigations.

1 March 2021
Verified
Journal Article
Closed access
NANuzhat Arshad
Nuzhat Arshad
MYMuhammad Yaseen
Muhammad Yaseen
JAMSHED HASHIMJAMSHED HASHIM
JAMSHED HASHIM
IUIrfan Ullah
Irfan Ullah
RKRasool Khan
Rasool Khan
UKUmme Attia Kulsoom
Umme Attia Kulsoom
Four series of tetrahydro-2H-1,3,5-thiadiazine thione derivatives were screened for their in vitro antiproliferative activities against two human cancerous PC3 and HeLa cell lines. The cytotoxicity of all the compounds (series A-D) was also determined on mammalian mouse fibroblast 3T3 cells. Most of the compounds showed significant anticancer potential against both cancer cell lines within the range of IC50 = 6.4-29.9 and 2.4-23.8 mu M respectively when compared with standard doxorubicin (IC50 = 0.3 mu M). All compounds demonstrated a notable selectivity for Hela cells and found either non-toxic or relatively less toxic for 3T3 cell lines model. The structure-activity relationship indicated that antiproliferative activity mainly influenced by the nature and position of substituents at thidiazine nucleus. In general, the presence of aryl groups for example 3,4-(OMe)(2)center dot Bzl and CH(Ph)Me at N-3 position resulted in a significant activity. Under enzymatic hydrolysis, complete conversion (100%) of ester derivative of thiadiazine thione (10a) into its acidic counterpart (7c) was achieved during 20 min which indicated that these types of THTT ester derivatives can be a possible lead for future investigations as prodrug anticancer probes.